{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:54:38Z","timestamp":1790837678563,"version":"4.1.0"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2011,9,20]],"date-time":"2011-09-20T00:00:00Z","timestamp":1316476800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0024930","type":"journal-article","created":{"date-parts":[[2011,9,20]],"date-time":"2011-09-20T20:56:22Z","timestamp":1316552182000},"page":"e24930","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["RNA Oxidation Adducts 8-OHG and 8-OHA Change with A\u03b242 Levels in Late-Stage Alzheimer's Disease"],"prefix":"10.1371","volume":"6","author":[{"given":"Adam M.","family":"Weidner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa A.","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina L.","family":"Beckett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana M.","family":"Niedowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy L. S.","family":"Dowling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey V.","family":"Matveev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"LeVine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Lovell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Paul","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,9,20]]},"reference":[{"key":"ref1","first-page":"1","article-title":"Deaths: Preliminary Data for 2009.","volume":"59","author":"KD Kochanek","year":"2011","journal-title":"National Vital Statistics Reports"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S1471-4914(01)02173-6","article-title":"Evidence of oxidative damage in Alzheimer&apos;s disease brain: central role for amyloid beta-peptide.","volume":"7","author":"DA Butterfield","year":"2001","journal-title":"Trends Mol Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer&apos;s disease: the amyloid cascade hypothesis.","volume":"256","author":"JA Hardy","year":"1992","journal-title":"Science"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.neurobiolaging.2004.08.002","article-title":"Mean age of onset in familial Alzheimer&apos;s disease is determined by amyloid beta 42.","volume":"26","author":"M Duering","year":"2005","journal-title":"Neurobiol Aging"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1001\/archneur.65.7.906","article-title":"Distinct pools of beta-amyloid in Alzheimer disease-affected brain: a clinicopathologic study.","volume":"65","author":"JR Steinerman","year":"2008","journal-title":"Arch Neurol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/1521654031000066820","article-title":"DSCR1(Adapt78)\u2013a Janus gene providing stress protection but causing Alzheimer&apos;s disease?","volume":"55","author":"G Ermak","year":"2003","journal-title":"IUBMB Life"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00401-009-0532-1","article-title":"Classification and basic pathology of Alzheimer disease.","volume":"118","author":"C Duyckaerts","year":"2009","journal-title":"Acta Neuropathol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1750-3639.2008.00244.x","article-title":"Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons.","volume":"20","author":"PT Nelson","year":"2010","journal-title":"Brain Pathol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.freeradbiomed.2008.01.002","article-title":"Nucleic acid oxidation in Alzheimer disease.","volume":"44","author":"PI Moreira","year":"2008","journal-title":"Free Radic Biol Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0891-5849(02)00794-3","article-title":"Lipid peroxidation and protein oxidation in Alzheimer&apos;s disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress.","volume":"32","author":"DA Butterfield","year":"2002","journal-title":"Free Radic Biol Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0021-9258(18)48474-8","article-title":"8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G----T and A----C substitutions.","volume":"267","author":"KC Cheng","year":"1992","journal-title":"J Biol Chem"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1523\/JNEUROSCI.19-06-01959.1999","article-title":"RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer&apos;s disease.","volume":"19","author":"A Nunomura","year":"1999","journal-title":"J Neurosci"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s11064-006-9071-5","article-title":"Decreased RNA, and increased RNA oxidation, in ribosomes from early Alzheimer&apos;s disease.","volume":"31","author":"Q Ding","year":"2006","journal-title":"Neurochem Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"40544","DOI":"10.1074\/jbc.M508772200","article-title":"Repair of formamidopyrimidines in DNA involves different glycosylases: role of the OGG1, NTH1, and NEIL1 enzymes.","volume":"280","author":"J Hu","year":"2005","journal-title":"J Biol Chem"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1046\/j.1471-4159.1999.0720771.x","article-title":"Increased DNA oxidation and decreased levels of repair products in Alzheimer&apos;s disease ventricular CSF.","volume":"72","author":"MA Lovell","year":"1999","journal-title":"J Neurochem"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1006\/nbdi.2002.0477","article-title":"Oxidative damage to nucleic acids in human prion disease.","volume":"9","author":"M Guentchev","year":"2002","journal-title":"Neurobiol Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0002-9440(10)65396-5","article-title":"Parkinson&apos;s disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons.","volume":"154","author":"J Zhang","year":"1999","journal-title":"Am J Pathol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1212\/WNL.55.3.370","article-title":"\u201cPreclinical\u201d AD revisited: neuropathology of cognitively normal older adults.","volume":"55","author":"FA Schmitt","year":"2000","journal-title":"Neurology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.neulet.2008.11.006","article-title":"Alzheimer&apos;s-type neuropathology in the precuneus is not increased relative to other areas of neocortex across a range of cognitive impairment.","volume":"450","author":"PT Nelson","year":"2009","journal-title":"Neurosci Lett"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.nbd.2007.06.002","article-title":"Abeta solubility and deposition during AD progression and in APPxPS-1 knock-in mice.","volume":"27","author":"MP Murphy","year":"2007","journal-title":"Neurobiol Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.nbd.2010.05.018","article-title":"Effects of nonsteroidal anti-inflammatory drugs on amyloid-beta pathology in mouse skeletal muscle.","volume":"39","author":"TL Beckett","year":"2010","journal-title":"Neurobiol Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ab.2004.08.014","article-title":"Alzheimer&apos;s beta-peptide oligomer formation at physiologic concentrations.","volume":"335","author":"H LeVine 3rd","year":"2004","journal-title":"Anal Biochem"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"8532","DOI":"10.1523\/JNEUROSCI.23-24-08532.2003","article-title":"Amyloid-beta immunization effectively reduces amyloid deposition in FcRgamma\u2212\/\u2212 knock-out mice.","volume":"23","author":"P Das","year":"2003","journal-title":"J Neurosci"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1172\/JCI25410","article-title":"Anti-Abeta42- and anti-Abeta40-specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model.","volume":"116","author":"Y Levites","year":"2006","journal-title":"J Clin Invest"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00401-009-0583-3","article-title":"Deficient high-affinity binding of Pittsburgh compound B in a case of Alzheimer&apos;s disease.","volume":"119","author":"RF Rosen","year":"2010","journal-title":"Acta Neuropathol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.neurobiolaging.2009.02.011","article-title":"PIB binding in aged primate brain: enrichment of high-affinity sites in humans with Alzheimer&apos;s disease.","volume":"32","author":"RF Rosen","year":"2011","journal-title":"Neurobiol Aging"},{"key":"ref27","article-title":"Purification of RNA using TRIzol (TRI reagent).","volume":"2010","author":"DC Rio","year":"2010","journal-title":"Cold Spring Harb Protoc"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1471-4159.2005.03053.x","article-title":"Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer&apos;s disease.","volume":"93","author":"J Wang","year":"2005","journal-title":"J Neurochem"},{"key":"ref29","first-page":"65","article-title":"A Simple Sequentially Rejective Multiple Test Procedure.","volume":"6","author":"S Holm","year":"1979","journal-title":"Scandinavian Journal of Statistics"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"8649","DOI":"10.1021\/ja010996t","article-title":"Influence of intervening mismatches on long-range guanine oxidation in DNA duplexes.","volume":"123","author":"PK Bhattacharya","year":"2001","journal-title":"J Am Chem Soc"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/jnen\/60.8.759","article-title":"Oxidative damage is the earliest event in Alzheimer disease.","volume":"60","author":"A Nunomura","year":"2001","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1021\/ja972331q","article-title":"Effect of guanine stacking on the oxidation of 8-oxoguanine in B-DNA.","volume":"120","author":"F Prat","year":"1998","journal-title":"J Am Chem Soc"},{"key":"ref33","article-title":"High-molecular weight Abeta-oligomers and protofibrils are the predominant Abeta-species in the native soluble protein fraction of the AD brain.","author":"AR Upadhaya","year":"2011","journal-title":"J Cell Mol Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1080\/15216540701283882","article-title":"Soluble protein oligomers as emerging toxins in Alzheimer&apos;s and other amyloid diseases.","volume":"59","author":"ST Ferreira","year":"2007","journal-title":"IUBMB Life"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s00109-003-0464-5","article-title":"Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution.","volume":"81","author":"M Stefani","year":"2003","journal-title":"J Mol Med"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/brain\/awq065","article-title":"The presence of sodium dodecyl sulphate-stable Abeta dimers is strongly associated with Alzheimer-type dementia.","volume":"133","author":"JM Mc Donald","year":"2010","journal-title":"Brain"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3233\/JAD-2010-1221","article-title":"Alzheimer&apos;s disease and the amyloid-beta peptide.","volume":"19","author":"MP Murphy","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes.","volume":"82","author":"H Braak","year":"1991","journal-title":"Acta Neuropathol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"7497","DOI":"10.1093\/nar\/gkm821","article-title":"Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer&apos;s disease.","volume":"35","author":"MA Lovell","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.nbd.2007.07.030","article-title":"Oxidatively modified RNA in mild cognitive impairment.","volume":"29","author":"MA Lovell","year":"2008","journal-title":"Neurobiol Dis"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1750-3639.2010.00375.x","article-title":"Changes with age in the activities of beta-secretase and the Abeta-degrading enzymes neprilysin, insulin-degrading enzyme and angiotensin-converting enzyme.","volume":"20","author":"JS Miners","year":"2010","journal-title":"Brain Pathol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3233\/JAD-2010-101395","article-title":"Accumulation of insoluble amyloid-beta in down&apos;s syndrome is associated with increased BACE-1 and neprilysin activities.","volume":"23","author":"JS Miners","year":"2011","journal-title":"J Alzheimers Dis"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0024930","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,5]],"date-time":"2021-12-05T23:09:44Z","timestamp":1638745784000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0024930"}},"subtitle":[],"editor":[{"given":"Mark R.","family":"Cookson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,9,20]]},"references-count":42,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2011,9,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0024930","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,20]]}}}